RADXRadiopharm Theranostics Limited American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key: 20768
Ticker: RADX
Type: ADRC — American Depository Receipt Common
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2024-11-27
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: RADX

Detail

Enriched 2026-08-14 20:47

Market cap: $21,915,198.7
Shares outstanding (class): 13,095,700
Shares outstanding (weighted): 7,883,165
SIC: —
Employees: 14
Location: —
Homepage: https://www.radiopharmtheranostics.com
Description: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Market cap and share counts drift.

Funds holding this security

as of 2026-03-31

No reported positions at this date.

Positions are reached through OpenFIGI-resolved ISINs. A security with no resolved ISIN cannot be found this way even if funds do hold it.

Funds holding this security

Identifiers

master.security_identifier

TICKERRADX
FIGI_COMPOSITEBBG01PT2ZTY8
FIGI_SHARE_CLASSBBG01PT2ZVT9
CIK0001949257

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: Radiopharm Theranostics is a clinical-stage biopharmaceutical company developing radiopharmaceuticals for cancer treatment.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.